Un fournisseur mondial signe un accord à long terme avec Vertex Pharmaceuticals pour CASGEVYMC KAISERAUGST, Suisse, 23 janvier 2024 /PRNewswire/ — Solvias, fournisseur mondial d’analyses de chimie, de fabrication et de contrôle (CMC), a annoncé aujourd’hui qu’elle effectuera des services de tests analytiques de libération sur la première thérapie cellulaire d’édition génomique CRISPR/Cas9 au monde. La… Continue reading Solvias va effectuer des tests de libération sur la première thérapie d’édition génique CRISPR au monde
Category: Newswire
Solvias voert releasetests uit voor ‘s werelds eerste CRISPR-behandeling met genbewerkingstechnologie
Wereldwijde leverancier tekent langetermijncontract met Vertex Pharmaceuticals voor CASGEVY™ KAISERAUGST, Zwitserland, 23 januari 2024 /PRNewswire/ — Solvias, een wereldwijde leverancier van analysediensten op het gebied van chemie, productie en controle (CMC), kondigde vandaag aan dat het testanalyses zal uitvoeren voor de release van ‘s werelds eerste celbehandeling met behulp van CRISPR/Cas9-genbewerkingstechnologie. Het bedrijf heeft een… Continue reading Solvias voert releasetests uit voor ‘s werelds eerste CRISPR-behandeling met genbewerkingstechnologie
Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy
Global Provider Signs Long-Term Agreement with Vertex Pharmaceuticals for CASGEVY™ KAISERAUGST, Switzerland, Jan. 23, 2024 /PRNewswire/ — Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release testing services on the world’s first CRISPR/Cas9 genome-edited cell therapy. The company has signed a long-term agreement with Vertex… Continue reading Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy
Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy
Global Provider Signs Long-Term Agreement with Vertex Pharmaceuticals for CASGEVY™ KAISERAUGST, Switzerland, Jan. 23, 2024 /PRNewswire/ — Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release testing services on the world’s first CRISPR/Cas9 genome-edited cell therapy. The company has signed a long-term agreement with Vertex… Continue reading Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy
Ares, Eurazeo, Barings Among Top 2023 European Direct Lenders – Lower Mid Market Deals Account for 80% of Transactions Despite Record Unitranche Size Raised
NEW YORK, Jan. 23, 2024 /PRNewswire/ — Reorg, a global provider of credit data, analysis and intelligence, has released its 2023 European Direct Lender league tables data. The league tables rank European direct lender activity in 2023 across factors including region and sub-region, loan size and sector. Additionally, the report explores overall deal flow in 2023… Continue reading Ares, Eurazeo, Barings Among Top 2023 European Direct Lenders – Lower Mid Market Deals Account for 80% of Transactions Despite Record Unitranche Size Raised
Colin Crooks, vétéran de Shell, est nommé PDG du fournisseur de solutions environnementales ACT
Colin Crooks rejoint ACT alors que le marché de la décarbonisation devrait tripler pour atteindre 4 000 milliards de dollars d’ici 2028 AMSTERDAM, 23 janvier 2024 /PRNewswire/ — Colin Crooks, ancien PDG et président du conseil d’administration de Shell Energy Retail et plus récemment vice-président principal de Shell pour les énergies renouvelables et les solutions énergétiques en Europe, rejoindra le groupe ACT… Continue reading Colin Crooks, vétéran de Shell, est nommé PDG du fournisseur de solutions environnementales ACT
CMI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cummins Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Jan. 23, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or “the Company”) (NYSE: CMI) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… Continue reading CMI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cummins Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Harbr and AWS partner to solve the ‘last mile’ for data
LONDON, Jan. 23, 2024 /PRNewswire/ — Harbr announced today that its ‘last mile’ data solution is available for provisioning in AWS Marketplace. This extends the relationship with Amazon Web Services (AWS) to solve the last mile for data, making it easier than ever to deploy a private data marketplace. The last mile of data is… Continue reading Harbr and AWS partner to solve the ‘last mile’ for data
Ares, Eurazeo, Barings Among Top 2023 European Direct Lenders – Lower Mid Market Deals Account for 80% of Transactions Despite Record Unitranche Size Raised
NEW YORK, Jan. 23, 2024 /PRNewswire/ — Reorg, a global provider of credit data, analysis and intelligence, has released its 2023 European Direct Lender league tables data. The league tables rank European direct lender activity in 2023 across factors including region and sub-region, loan size and sector. Additionally, the report explores overall deal flow in 2023… Continue reading Ares, Eurazeo, Barings Among Top 2023 European Direct Lenders – Lower Mid Market Deals Account for 80% of Transactions Despite Record Unitranche Size Raised
Shell Veteran Colin Crooks Appointed CEO of Environmental Solutions Provider ACT
Crooks joins ACT as decarbonization market expected to triple in size to $4 trillion by 2028 AMSTERDAM, Jan. 23, 2024 /PRNewswire/ — Colin Crooks, former CEO and Board Chair of Shell Energy Retail and most recently Shell Senior Vice President of Renewables and Energy Solutions Europe, will join ACT Group as CEO effective April 1, 2024.… Continue reading Shell Veteran Colin Crooks Appointed CEO of Environmental Solutions Provider ACT